PEG vs SUPN · P/E 18, rev $10.29B vs rev $661.8M
Public Service Enterprise Group Inc (PEG) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the PEG and SUPN stock pages for the full models.
Not investment advice.